Who Owns Grace Therapeutics Stock?
NASDAQ: GRCEHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Ownership breakdown
- Held by institutions
- 31.51%
- Held by insiders
- 18.68%
- Institutional holders
- 40
- Institutions 31.5%
- Insiders 18.7%
- Public and other 49.8%
Who owns Grace Therapeutics stock?
Institutional investors own about 31.5% of Grace Therapeutics's shares, spread across 40 institutions that file 13F reports. That level of institutional ownership is relatively low, leaving more of the stock with retail investors and insiders. Insiders, including executives, directors and large founding shareholders, hold 18.68% of GRCE.
The largest institutional holders are Cerity Partners LLC (4.04%), Eversept Partners, LP (3.67%) and Bank of America Corporation (2.35%). Together, the top 10 institutions control 16.6% of shares outstanding. In their latest filings, 7 of the top 10 institutions increased their GRCE positions and 2 reduced them.
Summary generated from market data by MetaCap's automated system. Methodology
Top institutional holders of GRCE
| Institution | Shares | % Held | Change |
|---|---|---|---|
| Cerity Partners LLC | 849.05K | 4.04% | 0.0% |
| Eversept Partners, LP | 772.90K | 3.67% | +2.1% |
| Bank of America Corporation | 494.70K | 2.35% | -0.0% |
| Vanguard Capital Management LLC | 411.71K | 1.96% | +2.5% |
| Citadel Advisors Llc | 349.74K | 1.66% | +254.2% |
| Maven Securities Limited | 200.00K | 0.95% | +100.0% |
| Birchview Capital, LP | 120.00K | 0.57% | +140.0% |
| Cantor Fitzgerald, L.P. | 100.00K | 0.48% | +100.0% |
| Two Sigma Investments, LP | 96.89K | 0.46% | +100.0% |
| Jane Street Group, LLC | 89.44K | 0.43% | -46.5% |
% held is the share of total shares outstanding. Change is the percentage change in the position since the holder's previous 13F filing.
Top mutual fund and ETF holders of GRCE
| Fund | Shares | % Held |
|---|---|---|
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 400.35K | 1.90% |
| iShares Trust-iShares Micro-Cap ETF | 34.95K | 0.17% |
| TIFF INVESTMENT PROGRAM-TIFF Multi-Asset Fund | 16.24K | 0.08% |
| VANGUARD VALLEY FORGE FUNDS-Vanguard Balanced Index Fund | 11.36K | 0.05% |
| Fidelity Concord Street Trust-Fidelity Nasdaq Composite Index Fund | 3.21K | 0.02% |
| EQ Advisors Trust-1290 VT Micro Cap Portfolio | 2.35K | 0.01% |
| John Hancock Variable Insurance Trust-Total Stock Market Index Trust | 778 | 0.00% |
Frequently asked questions
Who is the largest shareholder of Grace Therapeutics?
Cerity Partners LLC is the largest institutional shareholder of GRCE, owning 4.04% of shares outstanding (849.05K shares) as of its latest 13F filing.
What percentage of Grace Therapeutics is owned by institutions?
Institutions own about 31.5% of GRCE shares and 38.7% of the public float.
How much of Grace Therapeutics do insiders own?
Insiders, such as officers and directors, own about 18.68% of GRCE shares outstanding.
Where does institutional ownership data come from?
Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.